GlaxoSmithKline



Ebit Zmiana Data
AbbVie USD 5.24B 1.5B 2024-12
Alcon AG USD 498M 3M 2024-12
Almirall EUR 50.09M 65.59M 2024-06
Amgen USD 4.03B 11M 2024-12
argenx SE USD 14.19M 28.62M 2024-09
AstraZeneca USD 4.2B 119M 2024-12
Bayer EUR 855M 588M 2024-12
Biogen USD 644.1M 100.9M 2024-12
Bristol-Myers Squibb USD 4.21B 500M 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
Fresenius EUR 646M 94M 2024-12
Fresenius Medical Care EUR 489M 15M 2024-12
Galapagos EUR -62721000 8.42M 2024-12
Genmab DKK 2.16B 58M 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
Glaxosmithkline GBP 1.83B 1.76B 2024-12
GRIFOLS EUR 269.49M 73.1M 2024-06
Hikma Pharmaceutical USD 402M 96M 2024-06
Lonza CHF 727M 193M 2024-12
Merck EUR 1.1B 305M 2024-09
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Novo Nordisk 33.82B 7.89B 2024-09
Orion EUR 92.7M 109.3M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Philips EUR 637M 286M 2024-12
Recordati EUR 134.8M 30.76M 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.08B 1.69B 2024-12
Smith & Nephew USD 578M 107M 2024-12
UCB EUR 334M 163M 2024-06



GlaxoSmithKline - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.